Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 285-360-9 | CAS number: 85085-29-6 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Cupressus funebris, Cupressaceae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 07 Jun 2017 - 06 Jul 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2010
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- 2003
- Guideline:
- other: EC, No 440/2008, part B: "Skin Sensitization: Local Lymph Node Assay"
- Version / remarks:
- 2008
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Cypress, Cupressus funebris, ext.
- EC Number:
- 285-360-9
- EC Name:
- Cypress, Cupressus funebris, ext.
- Cas Number:
- 85085-29-6
- Molecular formula:
- Not applicable due to UVCB nature of the substance
- IUPAC Name:
- Essential oil of Cedarwood obtained from the wood of Cupressus funebris (Cupressaceae) by steam distillation
- Test material form:
- other: Pale yellow to yellow liquid
- Remarks:
- could crystallize
- Details on test material:
- - Name of test material (as cited in study report): Cedarwood Oil China
- Substance type: pure substance
- Physical state: liquid
- Analytical purity: no data
- Lot/batch No.: confidential information
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Batch 1002515317
- Expiration date of the lot/batch: 31 August 2017
- Purity: 100.0% (UVCB)
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: At room temperature
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: homogenised in Acetone/Olive oil (4:1 v/v)
- Final dilution of a dissolved solid, stock liquid or gel: 25% w/w
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA:J
- Remarks:
- Inbred
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known: SPF
- Age at study initiation: Young adult animals (approximately 9 weeks old)
- Weight at study initiation: 18.1 to 23.7 g
- Housing: polycarbonate cages (Makrolon MIII type; height 18 cm.)
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days before the commencement of dosing
- Indication of any skin lesions: health inspection was performed
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 to 24°C
- Humidity (%): 40 to 70%
- Air changes (per hr): 10 or greater air changes per hour with 100% fresh air
- Photoperiod (hrs dark / hrs light): 12 hour light/12 hour dark
- IN-LIFE DATES: From:07 Jun 2017 (start dosing) To: 03 jul 2017
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 0, 5, 10 and 25%
- No. of animals per dose:
- 5
- Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility: Soluble up to 100%
- Irritation: Very slight erythema, scaliness and scabs were noted for all animals between Days 2 and 6.
- Systemic toxicity: Hunched posture, piloerection and/or lethargy was noted for the animals treated at 100% on Days 3. Piloerection was noted for one animal treated at 50% on Day 3.
- Ear thickness measurements: Variations in ear thickness during the observation period were more than 25% from Day 1 pre-dose values for animals treated at 50% and 100%.
MAIN STUDY
According to OECD TG 429.
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay
- Criteria used to consider a positive response: the test item is regarded as a sensitiser in the LLNA if the exposure to at least one concentration of the test item resulted in an incorporation of 3H-methyl thymidine at least 3-fold or greater than that recorded in control mice, as indicated by the stimulation index.
TREATMENT PREPARATION AND ADMINISTRATION:
The dosing formulations were prepared daily and dosed within 4 hours after adding the vehicle to the test item.
The dosing formulations were kept at room temperature until dosing.
The dorsal surface of both ears was topically treated (25 μL/ear), at approximately the same time on each day. The formulation was stirred with a magnetic stirrer immediately prior to dosing.
The control animals were treated in the same way as the experimental animals, except that the vehicle was administered instead of the test item. - Positive control substance(s):
- other: Historical control
- Statistics:
- All results presented in the tables of the report are calculated using values as per the raw data rounding procedure and may not be exactly reproduced from the individual data presented. DPM values are presented for each animal and for each dose group.
A Stimulation Index (SI) is calculated for each group using the individual SI values. The individual SI is the ratio of the DPM/animal compared to the DPM/vehicle control group mean.
Results and discussion
- Positive control results:
- For both scientific and animal welfare reasons, no concurrent positive control group was included in the study. An database is available with reliability checks performed each half year during at least the recent 9 years showing reproducible and consistent positive results.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 9.1
- Variability:
- 1.9
- Test group / Remarks:
- 25% w/w
- Key result
- Parameter:
- SI
- Value:
- 3.3
- Variability:
- 0.7
- Test group / Remarks:
- 10% w/w
- Key result
- Parameter:
- SI
- Value:
- 3.1
- Variability:
- 0.7
- Test group / Remarks:
- 5% w/w
- Key result
- Parameter:
- EC3
- Remarks:
- %
- Value:
- 3.5
- Test group / Remarks:
- The EC3 value was determined using a log-linear extrapolation according to Ryan et al (2007)
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
Mean DPM per lymph node:
- Vehicle control group: 165 +/- 27
- 5%: 515 +/- 74
- 10%: 541 +/- 65
- 25%: 1502 +/- 190
DETAILS ON STIMULATION INDEX CALCULATION
The nodes were pooled for each animal. DPM values are presented for each animal and for each dose group. A Stimulation Index (SI) is calculated for each group using the individual SI values. The individual SI is the ratio of the DPM/animal compared to the DPM/vehicle control group mean.
EC3 CALCULATION
The EC3 value (the estimated test item concentration that will give a SI =3) was determined, using a log-linear extrapolation as described by Ryan et al. Extrapolating local lymph node assay EC3 values to estimate relative sensitizing potency. Cutan Ocul Toxicol 2007;26:135-145.
CLINICAL OBSERVATIONS:
One animal in the vehicle group died during injection of thymidine due to a non-test item related technical error. During necropsy no abnormalities were observed. No further mortality occurred and no clinical signs of systemic toxicity were observed in the animals of the main study.
BODY WEIGHTS
Body weights and body weight gain of experimental animals remained in the same range as controls over the study period.
Applicant's summary and conclusion
- Interpretation of results:
- other: sensitising
- Remarks:
- based on CLP criteria
- Conclusions:
- Under the conditions of the test Cedarwood Chinese Oil needs to be classified as skin sensitizer. The results indicate that the test item could elicit a SI ≥ 3. An EC3 value of 3.5% was calculated. Based on the results of this study the test substance should therefore be classified as a skin sensitizer (Skin Sens. 1B / H317) in accordance with the CLP Regulation (1272/2008/EC).
- Executive summary:
An LLNA, skin sensitization study was performed according to OECD TG 429 and in compliance with GLP. 4 mice per test group were exposed to 0, 5, 10 and 25% w/w Cedarwood Chinese Oil. Historical positive control tests were performed with α-Hexylcinnamaldehyde. The animals did not show any treatment related clinical signs during the course of the study. One animal in the vehicle group died during injection of thymidine due to a non-test item related technical error. In this study Stimulation Indices (S.I.) of 3.1, 3.3 and 9.1 were determined with the test item at concentrations of 5, 10 and 25% w/w in acetone/olive oil (4:1 v/v), respectively. Since the lowest dose could elicit a SI ≥ 3, the EC3 value was calculated by log-linear extrapolation according to the method described by Ryan et al (2007). An EC3 value of 3.5% was calculated. The test substance should therefore be classified as a skin sensitizer (Skin Sens. 1B / H317) in accordance with the CLP Regulation (1272/2008/EC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.